Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L9YX
|
|||
| Former ID |
DAP000798
|
|||
| Drug Name |
Dihydroxyaluminium
|
|||
| Synonyms |
(2-Aminoacetoxy)dihydroxyaluminum; Dihydroxyaluminium glycinate; Dihydroxyaluminum aminoacetate; 41354-48-7; Robalate; Prodexin; Hyperacid; Alilac; (Glycinato)dihydroxyaluminum; Alminate; (T-4)-(Glycinato-N,O)dihydroxyaluminum; Dihydroxyaluminum aminoacetate [USAN:USP]; C2H6AlNO4; Dihydroxoaluminium glycinat; Aluminum glycinate, AldrichCPR; DTXSID3044546; (Glycinato-N,O)dihydroxyaluminum; 51484-68-5 (proacid); MolPort-023-220-319; 13682-92-3 (Parent); (Glycinato)dihydroxyaluminum hydrate; EINECS 237-193-8; Aluminum, (glycinato-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Skin inflammation [ICD-11: EF20.Y; ICD-9: 709.8] | Approved | [1] | |
| Therapeutic Class |
Antiinflammatory Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C2H8AlNO4
|
|||
| Canonical SMILES |
C(C(=O)O[Al])N.O.O
|
|||
| InChI |
1S/C2H5NO2.Al.2H2O/c3-1-2(4)5;;;/h1,3H2,(H,4,5);;2*1H2/q;+1;;/p-1
|
|||
| InChIKey |
RBNPZEHAODHBPZ-UHFFFAOYSA-M
|
|||
| CAS Number |
CAS 13682-92-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| SuperDrug ATC ID |
A02AB07
|
|||
| SuperDrug CAS ID |
cas=013682923
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Troponin C (TN-C) | Target Info | Stimulator | [2], [3] |
| KEGG Pathway | Calcium signaling pathway | |||
| Cardiac muscle contraction | ||||
| Adrenergic signaling in cardiomyocytes | ||||
| Hypertrophic cardiomyopathy (HCM) | ||||
| Dilated cardiomyopathy | ||||
| Pathwhiz Pathway | Muscle/Heart Contraction | |||
| Reactome | Striated Muscle Contraction | |||
| WikiPathways | Striated Muscle Contraction | |||
| Muscle contraction | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drug information of Dihydroxyaluminium, Health Canada, 2007. | |||
| REF 2 | A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med. 2009 Dec;9(4):303-12. | |||
| REF 3 | Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements. Pharmacol Toxicol. 2000 Mar;86(3):135-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.